novo nordisk lawsuit semaglutide Ozempic Parent Company Is Cracking Down Ozempic maker Novo Nordisk sues

Patients who rotate rigorously report fewer injection site reactions (redness, swelling, itching) and more consistent appetite suppression week-to-week

The SELECT trial proved that GLP-1 agonism alone reduces major cardiovascular events by 20% in at-risk patients

Cagrilintide is an investigational amylin-receptor agonist studied for its potential roles in satiety signaling, metabolic regulation, and feeding-behavior research

Shortness of Breath & Dizziness: Feeling breathless or lightheaded, even with little physical activity

RELATED: The ultimate preconception guide: What to do when youre ready to get pregnant What are GLP-1s

Anita Munoz